Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30


Clinical Value of High Mobility Group Box 1 and the Receptor for Advanced Glycation End-products in Head and Neck Cancer: A Systematic Review.

Nguyen A, Bhavsar S, Riley E, Caponetti G, Agrawal D.

Int Arch Otorhinolaryngol. 2016 Oct;20(4):382-389. Review.


Regulation of the IL-10-driven macrophage phenotype under incoherent stimuli.

Chuang Y, Hung ME, Cangelose BK, Leonard JN.

Innate Immun. 2016 Nov;22(8):647-657. doi: 10.1177/1753425916668243.


Aggressiveness Niche: Can It Be the Foster Ground for Cancer Metastasis Precursors?

ElShamy WM, Sinha A, Said N.

Stem Cells Int. 2016;2016:4829106. doi: 10.1155/2016/4829106. Review.


The implication and potential applications of high-mobility group box 1 protein in breast cancer.

Sohun M, Shen H.

Ann Transl Med. 2016 Jun;4(11):217. doi: 10.21037/atm.2016.05.36. Review.


[Nle4, D-Phe7]-α-MSH Inhibits Toll-Like Receptor (TLR)2- and TLR4-Induced Microglial Activation and Promotes a M2-Like Phenotype.

Carniglia L, Ramírez D, Durand D, Saba J, Caruso C, Lasaga M.

PLoS One. 2016 Jun 30;11(6):e0158564. doi: 10.1371/journal.pone.0158564.


Mechanisms of microglial activation in models of inflammation and hypoxia: Implications for chronic intermittent hypoxia.

Kiernan EA, Smith SM, Mitchell GS, Watters JJ.

J Physiol. 2016 Mar 15;594(6):1563-77. doi: 10.1113/JP271502. Review.


Circulating HMGB1 and RAGE as Clinical Biomarkers in Malignant and Autoimmune Diseases.

Pilzweger C, Holdenrieder S.

Diagnostics (Basel). 2015 Jun 16;5(2):219-53. doi: 10.3390/diagnostics5020219. Review.


Selective inhibition of histone deacetylase 6 promotes survival in a rat model of hemorrhagic shock.

Chang Z, Li Y, He W, Liu B, Halaweish I, Bambakidis T, Liang Y, Alam HB.

J Trauma Acute Care Surg. 2015 Dec;79(6):905-10. doi: 10.1097/TA.0000000000000784.


Association of Upregulated HMGB1 and c-IAP2 Proteins With Hepatocellular Carcinoma Development and Progression.

Bi MR, Zhu LY, Yan BZ, Chen LY, Wang FX, Ma YJ, Yang BS.

Hepat Mon. 2014 Dec 15;14(12):e23552. doi: 10.5812/hepatmon.23552.


Antitumor immunity induced after α irradiation.

Gorin JB, Ménager J, Gouard S, Maurel C, Guilloux Y, Faivre-Chauvet A, Morgenstern A, Bruchertseifer F, Chérel M, Davodeau F, Gaschet J.

Neoplasia. 2014 Apr;16(4):319-28. doi: 10.1016/j.neo.2014.04.002.


The role of high mobility group box 1 (HMGB1) in colorectal cancer.

Süren D, Yıldırım M, Demirpençe Ö, Kaya V, Alikanoğlu AS, Bülbüller N, Yıldız M, Sezer C.

Med Sci Monit. 2014 Mar 31;20:530-7. doi: 10.12659/MSM.890531.


D-K6L 9 peptide combination with IL-12 inhibits the recurrence of tumors in mice.

Cichoń T, Smolarczyk R, Matuszczak S, Barczyk M, Jarosz M, Szala S.

Arch Immunol Ther Exp (Warsz). 2014 Aug;62(4):341-51. doi: 10.1007/s00005-014-0268-z.


HMGB1 in cancer: good, bad, or both?

Kang R, Zhang Q, Zeh HJ 3rd, Lotze MT, Tang D.

Clin Cancer Res. 2013 Aug 1;19(15):4046-57. doi: 10.1158/1078-0432.CCR-13-0495. Review.


Life after death: targeting high mobility group box 1 in emergent cancer therapies.

Guo ZS, Liu Z, Bartlett DL, Tang D, Lotze MT.

Am J Cancer Res. 2013;3(1):1-20.


Wogonin induced calreticulin/annexin A1 exposure dictates the immunogenicity of cancer cells in a PERK/AKT dependent manner.

Yang Y, Li XJ, Chen Z, Zhu XX, Wang J, Zhang LB, Qiang L, Ma YJ, Li ZY, Guo QL, You QD.

PLoS One. 2012;7(12):e50811. doi: 10.1371/journal.pone.0050811.


Altered local and systemic immune profiles underlie lymph node metastasis in breast cancer patients.

Zuckerman NS, Yu H, Simons DL, Bhattacharya N, Carcamo-Cavazos V, Yan N, Dirbas FM, Johnson DL, Schwartz EJ, Lee PP.

Int J Cancer. 2013 Jun 1;132(11):2537-47. doi: 10.1002/ijc.27933.


Alarmins: awaiting a clinical response.

Chan JK, Roth J, Oppenheim JJ, Tracey KJ, Vogl T, Feldmann M, Horwood N, Nanchahal J.

J Clin Invest. 2012 Aug;122(8):2711-9. doi: 10.1172/JCI62423. Review.


Identification and characterization of the lamprey high-mobility group box 1 gene.

Pang Y, Xiao R, Liu X, Li Q.

PLoS One. 2012;7(4):e35755. doi: 10.1371/journal.pone.0035755.

Items per page

Supplemental Content

Support Center